STRIvE-01: EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

EGFR806-specific CAR T-cell therapy - Cellevolve Bio, Seattle Children’s Therapeutics

http://clinicaltrials.gov/ct2/show/NCT03618381

Jul 17, 2023